Liangwei Wang Selected Research

sifalimumab

1/2020	Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study.
11/2016	Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
4/2013	Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liangwei Wang Research Topics

Disease

7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 04/2013
2	Herpes Zoster 01/2017 - 11/2016
2	Infections 11/2016 - 04/2013
1	Substance-Related Disorders (Drug Abuse) 05/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Glioma (Gliomas) 09/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Neutropenia 01/2018
1	Exanthema (Rash) 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Human Influenza (Influenza) 01/2017
1	Asthma (Bronchial Asthma) 01/2017

Drug/Important Bio-Agent (IBA)

6	Monoclonal AntibodiesIBA 01/2020 - 04/2013
4	Interferon Type IIBA 01/2021 - 01/2017
4	InterferonsIBA 01/2020 - 04/2013
4	anifrolumabIBA 01/2020 - 01/2017
3	sifalimumabIBA 01/2020 - 04/2013
2	Alprostadil (Muse)FDA LinkGeneric 01/2021 - 01/2018
1	Methamphetamine (Desoxyn)FDA LinkGeneric 05/2022
1	Long Noncoding RNAIBA 09/2020
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2020
1	CD40 Ligand (CD40L)IBA 01/2019
1	tezepelumabIBA 01/2017
1	CytokinesIBA 01/2017
1	Thymic Stromal LymphopoietinIBA 01/2017
1	GlucocorticoidsIBA 01/2017